As described by Pérez-Areales and coworkers, RHE-HUP seems to inhibit AChE [38], a prime target in AD, since the cholinergic deficit has been widely observed in AD patients and is directly responsible for the cognitive decline [75, 76]. Here, ACHE is linked to Mental deterioration.